SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-005551
Filing Date
2018-03-14
Accepted
2018-03-14 09:00:16
Documents
3
Period of Report
2018-03-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sbph-8k_20180314.htm 8-K 23374
2 EX-99.1 sbph-ex991_6.htm EX-99.1 23432
3 GRAPHIC g201803132044320606746.jpg GRAPHIC 5029
  Complete submission text file 0001564590-18-005551.txt   54962
Mailing Address 86 SOUTH STREET HOPKINTON MA 01748
Business Address 86 SOUTH STREET HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37718 | Film No.: 18688411
SIC: 2834 Pharmaceutical Preparations